MedPath

Antiplatelet therapy in endovascular treatment for intracranial aneurysms, a multi center cohort study (APT-ANswer study)

Not Applicable
Registration Number
JPRN-UMIN000044122
Lead Sponsor
Gifu University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
500
Inclusion Criteria

Not provided

Exclusion Criteria

(1) Patients who could not receive sufficient preoperati ve antiplatelet therapy due to emergency treatment for ruptured cerebral aneurysm, symptomatic cerebral an eurysm, etc. (2) In addition, patients who are judged to be inappro priate as targets by the judgment of the investigator.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Time from endovascular treatment to onset of thromb oembolic events related to target vessels, or death
Secondary Outcome Measures
NameTimeMethod
1) hemorrhagic events equivalent to ISTH major bleed ing 2) hemorrhagic events which required intervention by a medical professional 3) asymptomatic ischemic lesion on MRI-DWI 4) Ischemic event other than cerebrovascular disease
© Copyright 2025. All Rights Reserved by MedPath